Mary B Weitzel

Yaso Therapeutics Inc

$1,959,557

Attributed

$7,081,446

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY2011–25

$1M$750K$500K$250K$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,081,446 · 5

By mechanism

R44$6,497,313 · 3

R43$584,133 · 2

Top collaborators

Most similar at Yaso Therapeutics Inc

Same institution · by research overlap

Others in their field

Top investigators on “Contraceptive Agents”

Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
Myron S Cohen · Family Health International$91,263,426
Sharon L Hillier · Magee-Women'S Hospital Of Upmc$57,639,818
Clint Dart · Health Decisions, Inc.$32,678,557
Elizabeth Renata Brown · Fred Hutchinson Cancer Center$27,668,869
Christina Wang · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$21,476,354

Research focus

Contraceptive AgentsSmall Business Innovation Research GrantSafetyGrantVaginaClinical TrialsPhase I Clinical TrialsAnalytical MethodWomanPharmaceutical PreparationsSimplexvirusSperm CellOryctolagus CuniculusNeisseria GonorrhoeaeIn VitroNational Institute Of Child Health And Human DevelopmentToxicologyRattusProductionProtocols DocumentationSexually Transmitted DiseasesPreclinical EvaluationFundingPharmacologic Substance